439 related articles for article (PubMed ID: 27803169)
1. Development of a Live Attenuated Bivalent Oral Vaccine Against Shigella sonnei Shigellosis and Typhoid Fever.
Wu Y; Chakravarty S; Li M; Wai TT; Hoffman SL; Sim BK
J Infect Dis; 2017 Jan; 215(2):259-268. PubMed ID: 27803169
[TBL] [Abstract][Full Text] [Related]
2. Stable expression of Shigella sonnei form I O-polysaccharide genes recombineered into the chromosome of live Salmonella oral vaccine vector Ty21a.
Dharmasena MN; Hanisch BW; Wai TT; Kopecko DJ
Int J Med Microbiol; 2013 Apr; 303(3):105-13. PubMed ID: 23474241
[TBL] [Abstract][Full Text] [Related]
3. Stable Chromosomal Expression of Shigella flexneri 2a and 3a O-Antigens in the Live Salmonella Oral Vaccine Vector Ty21a.
Dharmasena MN; Osorio M; Takeda K; Stibitz S; Kopecko DJ
Clin Vaccine Immunol; 2017 Dec; 24(12):. PubMed ID: 29046309
[TBL] [Abstract][Full Text] [Related]
4. Salmonella enterica serovar Typhi Ty21a expressing human papillomavirus type 16 L1 as a potential live vaccine against cervical cancer and typhoid fever.
Fraillery D; Baud D; Pang SY; Schiller J; Bobst M; Zosso N; Ponci F; Nardelli-Haefliger D
Clin Vaccine Immunol; 2007 Oct; 14(10):1285-95. PubMed ID: 17687110
[TBL] [Abstract][Full Text] [Related]
5. Safety and antigenicity of typhoid-Shigella sonnei vaccine (strain 5076-1C).
Tramont EC; Chung R; Berman S; Keren D; Kapfer C; Formal SB
J Infect Dis; 1984 Feb; 149(2):133-6. PubMed ID: 6366077
[TBL] [Abstract][Full Text] [Related]
6. Core-linked LPS expression of Shigella dysenteriae serotype 1 O-antigen in live Salmonella Typhi vaccine vector Ty21a: preclinical evidence of immunogenicity and protection.
Xu DQ; Cisar JO; Osorio M; Wai TT; Kopecko DJ
Vaccine; 2007 Aug; 25(33):6167-75. PubMed ID: 17629369
[TBL] [Abstract][Full Text] [Related]
7. Studies in volunteers to evaluate candidate Shigella vaccines: further experience with a bivalent Salmonella typhi-Shigella sonnei vaccine and protection conferred by previous Shigella sonnei disease.
Herrington DA; Van de Verg L; Formal SB; Hale TL; Tall BD; Cryz SJ; Tramont EC; Levine MM
Vaccine; 1990 Aug; 8(4):353-7. PubMed ID: 2204243
[TBL] [Abstract][Full Text] [Related]
8. Construction of a potential bivalent vaccine strain: introduction of Shigella sonnei form I antigen genes into the galE Salmonella typhi Ty21a typhoid vaccine strain.
Formal SB; Baron LS; Kopecko DJ; Washington O; Powell C; Life CA
Infect Immun; 1981 Dec; 34(3):746-50. PubMed ID: 6174449
[TBL] [Abstract][Full Text] [Related]
9. Molecular cloning and characterization of genes for Shigella sonnei form I O polysaccharide: proposed biosynthetic pathway and stable expression in a live salmonella vaccine vector.
Xu DQ; Cisar JO; Ambulos N; Burr DH; Kopecko DJ
Infect Immun; 2002 Aug; 70(8):4414-23. PubMed ID: 12117952
[TBL] [Abstract][Full Text] [Related]
10. Prevention of shigellosis by a Salmonella typhi-Shigella sonnei bivalent vaccine.
Black RE; Levine MM; Clements ML; Losonsky G; Herrington D; Berman S; Formal SB
J Infect Dis; 1987 Jun; 155(6):1260-5. PubMed ID: 2437220
[TBL] [Abstract][Full Text] [Related]
11. Specific and cross-reactive immune response to oral Salmonella Typhi Ty21a and parenteral Vi capsular polysaccharide typhoid vaccines administered concomitantly.
Pakkanen SH; Kantele JM; Savolainen LE; Rombo L; Kantele A
Vaccine; 2015 Jan; 33(3):451-8. PubMed ID: 25433216
[TBL] [Abstract][Full Text] [Related]
12. Live oral typhoid vaccine Salmonella Typhi Ty21a - a surrogate vaccine against non-typhoid salmonella?
Kantele A; Pakkanen SH; Siitonen A; Karttunen R; Kantele JM
Vaccine; 2012 Nov; 30(50):7238-45. PubMed ID: 23084770
[TBL] [Abstract][Full Text] [Related]
13. Oral immunisation against typhoid fever in Indonesia with Ty21a vaccine.
Simanjuntak CH; Paleologo FP; Punjabi NH; Darmowigoto R; Soeprawoto ; Totosudirjo H; Haryanto P; Suprijanto E; Witham ND; Hoffman SL
Lancet; 1991 Oct; 338(8774):1055-9. PubMed ID: 1681365
[TBL] [Abstract][Full Text] [Related]
14. Vi Capsular Polysaccharide Produced by Recombinant
Xiong K; Zhu C; Chen Z; Zheng C; Tan Y; Rao X; Cong Y
Front Cell Infect Microbiol; 2017; 7():135. PubMed ID: 28484685
[TBL] [Abstract][Full Text] [Related]
15. [Construction of a typhoid-dysentery bivalent strain with typhoid ty21a and dysentery T32-Istrati strains].
Chen QY; Jiang LJ; Kong DC; Wang BR
Wei Sheng Wu Xue Bao; 1987 Dec; 27(4):362-8. PubMed ID: 3329424
[No Abstract] [Full Text] [Related]
16. A review of the current status of enteric vaccines.
Levine MM; Noriega F
P N G Med J; 1995 Dec; 38(4):325-31. PubMed ID: 9522876
[TBL] [Abstract][Full Text] [Related]
17. Development of recombinant vaccine candidate molecule against Shigella infection.
Chitradevi STS; Kaur G; Sivaramakrishna U; Singh D; Bansal A
Vaccine; 2016 Oct; 34(44):5376-5383. PubMed ID: 27591952
[TBL] [Abstract][Full Text] [Related]
18. Stable expression of Shigella dysenteriae serotype 1 O-antigen genes integrated into the chromosome of live Salmonella oral vaccine vector Ty21a.
Dharmasena MN; Osorio M; Filipova S; Marsh C; Stibitz S; Kopecko DJ
Pathog Dis; 2016 Nov; 74(8):. PubMed ID: 27655911
[TBL] [Abstract][Full Text] [Related]
19. Using a Human Challenge Model of Infection to Measure Vaccine Efficacy: A Randomised, Controlled Trial Comparing the Typhoid Vaccines M01ZH09 with Placebo and Ty21a.
Darton TC; Jones C; Blohmke CJ; Waddington CS; Zhou L; Peters A; Haworth K; Sie R; Green CA; Jeppesen CA; Moore M; Thompson BA; John T; Kingsley RA; Yu LM; Voysey M; Hindle Z; Lockhart S; Sztein MB; Dougan G; Angus B; Levine MM; Pollard AJ
PLoS Negl Trop Dis; 2016 Aug; 10(8):e0004926. PubMed ID: 27533046
[TBL] [Abstract][Full Text] [Related]
20. Cross-reactive immune response elicited by parenteral Vi polysaccharide typhoid vaccine against non-typhoid Salmonellae.
Pakkanen SH; Kantele JM; Herzog C; Kantele A
Vaccine; 2014 Jan; 32(5):544-51. PubMed ID: 24342246
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
